Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Subnormal parasympathetic activity after cardiac transplantation.

M L Smith1, K A Ellenbogen, D L Eckberg

  • 1Department of Medicine, McGuire Veterans Administration Medical Center, Richmond, Virginia 23249.

The American Journal of Cardiology
|November 15, 1990
PubMed
Summary

Heart period variability, a measure of parasympathetic activity, is lower in heart failure patients post-transplant. It improves significantly 3-6 months after cardiac transplantation, indicating recovery of autonomic function.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Human baroreflex rhythms persist during handgrip and muscle ischaemia.

Acta physiologica (Oxford, England)·2013
Same author

Comparative effectiveness of novel oral anticoagulants for atrial fibrillation: evidence from pair-wise and warfarin-controlled network meta-analyses.

HSR proceedings in intensive care & cardiovascular anesthesia·2013
Same author

Predicting sudden death in patients with mild to moderate chronic heart failure.

Heart (British Cardiac Society)·2004
Same author

Bursting into space: alterations of sympathetic control by space travel.

Acta physiologica Scandinavica·2003
Same author

Implantable cardioverter defibrillator T wave oversensing caused by hyperglycemia.

Pacing and clinical electrophysiology : PACE·2002
Same author

Electrophysiologic effects of a novel selective adenosine A1 agonist (CVT-510) on atrioventricular nodal conduction in humans.

Journal of cardiovascular pharmacology and therapeutics·2001

Area of Science:

  • Cardiology
  • Autonomic Neuroscience

Background:

  • Congestive heart failure (CHF) is associated with impaired autonomic function.
  • Orthotopic cardiac transplantation aims to restore cardiac function, but the recovery of autonomic control, particularly parasympathetic activity, requires investigation.

Purpose of the Study:

  • To assess baseline parasympathetic activity using heart period variability in patients with CHF before and after orthotopic cardiac transplantation.
  • To compare parasympathetic activity in transplanted patients with age-matched controls.
  • To investigate the temporal changes and influencing factors of parasympathetic activity post-transplantation.

Main Methods:

  • Heart period variability (standard deviation of 120 consecutive RR or PP intervals) was measured in 18 CHF patients pre- and post-transplant, and 16 controls.

Related Experiment Videos

  • Data were analyzed to compare groups and track changes over time (early vs. late post-transplant).
  • A stepwise regression model was used to identify factors influencing heart period variability.

    • Main Results:

    • Patients with CHF had significantly lower heart period variability than controls, both pre- and post-transplant.
    • Heart period variability in recipient atria showed no significant change early post-transplant (1-4 weeks) but increased significantly by 15-37 weeks.
    • Heart period variability was positively related to time post-transplant and inversely related to systolic arterial pressure and rejection severity.

    Conclusions:

    • Baseline parasympathetic activity does not significantly recover within the first month after cardiac transplantation.
    • Significant improvement in parasympathetic activity occurs between 3 and 6 months post-transplantation.
    • The donor heart does not appear to undergo vagal reinnervation, suggesting recovery is primarily from recipient autonomic pathways.